Endacof C

Endacof C

Endacof C Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Do not exceed recommended dosage.

  • Adults and children who have a chronic pulmonary disease or shortness of breath, or children who are taking other drugs, should not take this product unless directed by a doctor
  • trouble urinating due to an enlarged prostate gland
  • glaucoma
  • cough that occurs with excessive phlegm (mucus)
  • a breathing problem or persistent or chronic cough that lasts such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • sedatives or tranquilizers
  • symptoms last more than 7 days, come back or are accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

temporarily relieves:

  • cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants
  • the intensity of coughing
  • the impulse to cough to help you go to sleep
  • temporarily decreases runny nose and sneezing, itching of the nose and throat and itchy, watery eyes due to hay fever or other respiratory allergies.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Endacof C Manufacturers


  • Larken Laboratories, Inc.
    Endacof C (Codeine Phosphate And Chlorpheniramine Maleate) Liquid [Larken Laboratories, Inc.]

Login To Your Free Account